Trial Profile
Phase II study of capecitabine and gemcitabine in patients with metastatic colorectal cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Jul 2014
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Capecitabine
- Indications Colorectal cancer
- Focus Therapeutic Use
- 14 Jan 2008 Status changed from recruiting to completed.
- 22 Oct 2005 New trial record.